Advances in Targeted Therapy of Lymphoma
Abstract Lymphoma is the most common hematologic malignancy, and its incidence increases year by year. It is estimated that there are over 80 000 new cases of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) in 2015 and more than 20 000 deaths. In recent years, the 5-year survival...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Third Party Medicine International Publishing Group Co. Limited
2015-12-01
|
| Series: | Journal of International Translational Medicine |
| Subjects: | |
| Online Access: | http://www.jitm.hk/EN/abstract/abstract183.shtml |